Literature DB >> 23449090

Veno-occlusive disease following high dose melphalan.

Tuphan Kanti Dolai1, K S Nataraj, Maitreyee Bhattacharya, Malay Kumar Ghosh.   

Abstract

Hepatic veno-occlusive disease (VOD) is one of the complications following bone marrow transplantation. This complication is uncommon after HDT for autologous SCT (ASCT) in patients with multiple myeloma (MM). Here we report on a 54 years male with MM developed VOD on day 16 of transplant. The Patient was died due to multi-organ failure. The present case suggests that after HDT for ASCT in patients with MM can complicated with VOD.

Entities:  

Keywords:  Melphalan; Veno-occlusive disease

Year:  2011        PMID: 23449090      PMCID: PMC3311969          DOI: 10.1007/s12288-011-0100-4

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  6 in total

Review 1.  Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.

Authors:  Martha Wadleigh; Vincent Ho; Parisa Momtaz; Paul Richardson
Journal:  Curr Opin Hematol       Date:  2003-11       Impact factor: 3.284

2.  Vascular disorders of the liver.

Authors:  Laurie D DeLeve; Dominique-Charles Valla; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

3.  In situ immunophenotyping study of endothelial cells of the human hepatic sinusoid: results and functional implications.

Authors:  J Y Scoazec; G Feldmann
Journal:  Hepatology       Date:  1991-11       Impact factor: 17.425

4.  Hepatic veno-occlusive disease after tandem autologous stem cell transplantation conditioned by melphalan.

Authors:  Sana Intidhar Labidi; Catherine Sebban; Hervé Ghesquières; Emmanuele Virelizier Nicolas; Pierre Biron
Journal:  Int J Hematol       Date:  2008-08-12       Impact factor: 2.490

5.  Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.

Authors:  Enric Carreras; Laura Rosiñol; Maria José Terol; Adrián Alegre; Felipe de Arriba; José García-Laraña; José Luis Bello; Raimundo García; Angel León; Rafael Martínez; M Jesús Peñarrubia; Concha Poderós; Paz Ribas; Josep Maria Ribera; Jesús San Miguel; Joan Bladé; Juan José Lahuerta
Journal:  Biol Blood Marrow Transplant       Date:  2007-12       Impact factor: 5.742

Review 6.  Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.

Authors:  Shaji Kumar; Laurie D DeLeve; Patrick S Kamath; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2003-05       Impact factor: 7.616

  6 in total
  1 in total

1.  A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma.

Authors:  A Dispenzieri; A D'Souza; M A Gertz; K Laumann; G Wiseman; M Q Lacy; B LaPlant; F Buadi; S R Hayman; S K Kumar; D Dingli; W J Hogan; S M Ansell; D A Gastineau; D J Inwards; I N Micallef; L F Porrata; P B Johnston; M R Litzow; T E Witzig
Journal:  Bone Marrow Transplant       Date:  2017-09-04       Impact factor: 5.483

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.